|
Mike Grisham has extensive experience and success in growing high potential venture capital financed healthcare technology companies. Prior to co-founding CellPoint Diagnostics, Mr. Grisham spent four years as CEO of Living Microsystems Inc. developing pre-natal diagnostic products using a novel microfluidics-based rare cell detection technology. Living MicroSystems has raised $27 million in venture financing and is currently in clinical trials with a breakthrough product to non-invasively screen and diagnosis prenatal chromosomal abnormalities. Previously, Mr. Grisham was President and CEO of Paradigm Health Corporation. Paradigm is the preeminent medical management company for all healthcare aspects of complex catastrophic medical conditions. Prior to Paradigm, Mr. Grisham was CEO of Neurocare, Inc., a leading provider of rehabilitative services for traumatically brain-injured individuals. Mr. Grisham received his AB degree from the University of California, Berkeley and a Masters in Business Administration from the Stanford Graduate School of Business. | 